Figure 5.

Validating immune risk score prognostic predictive model in the testing set. (A) Kaplan–Meier curves for OS outcomes in the testing cohort divided by high- and low-risk score groups. (B) The time-dependent ROC curves for predicting 1-, 3-, and 5-year survival outcomes using this signature. (C) Risk score distribution in the testing cohort. (D) Vital statuses of patients in high- and low-risk patients. (E) Expression patterns for 14 immune-associated genes in the high- and low-risk score cohorts. (F) Nomogram developed for the prediction of probabilities for 1-, 3-, and 5-year OS outcomes in the testing cohort. Risk scores and other independent prognostic factors were incorporated in the nomogram. (G) Time-dependent ROC curves for prediction of 1-, 3-, and 5-year survival outcomes using the nomogram. (H) Calibration plot of nomogram in the training cohort according to the agreement between estimated and observed 1-, 3-, and 5-year outcomes. Dashed lines represent the nomograms’ ideal performance. (I) Decision curve analysis for 1-, 3-, and 5-year risk using the nomogram. Black line represents the hypothesis that no patient died after 1-, 3-, and 5-years.